Juhong Wang

776 total citations · 1 hit paper
17 papers, 507 citations indexed

About

Juhong Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juhong Wang has authored 17 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juhong Wang's work include RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Juhong Wang is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer, Lipids, and Metabolism (5 papers). Juhong Wang collaborates with scholars based in China, United States and United Kingdom. Juhong Wang's co-authors include Zhimin Lu, Fei Shao, Yibo Gao, Dong Guo, Xueying Yang, Wei Wang, Rongxuan Zhu, Jie He, Yannan Yang and Jie He and has published in prestigious journals such as Nature Communications, Journal of Agricultural and Food Chemistry and Cell Death and Disease.

In The Last Decade

Juhong Wang

17 papers receiving 506 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc

2024 57 citations Juhong Wang, Yannan Yang et al. Nature Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juhong Wang China	12	419	280	83	50	38	17	507
Mujie Ye China	16	400 1.0×	257 0.9×	81 1.0×	39 0.8×	21 0.6×	38	510
Shaorui Gu China	10	425 1.0×	271 1.0×	84 1.0×	66 1.3×	20 0.5×	16	527
Qiuchen Chen China	13	606 1.4×	443 1.6×	96 1.2×	49 1.0×	19 0.5×	17	694
Yuanchang Hu China	9	379 0.9×	221 0.8×	71 0.9×	35 0.7×	28 0.7×	14	502
Xuyang Hou China	12	304 0.7×	140 0.5×	69 0.8×	46 0.9×	21 0.6×	22	410
Fengyu Zhu China	10	454 1.1×	224 0.8×	88 1.1×	36 0.7×	72 1.9×	19	560
Chunlong Yang China	11	616 1.5×	313 1.1×	80 1.0×	53 1.1×	36 0.9×	16	672
Linxi Yang China	5	469 1.1×	292 1.0×	65 0.8×	46 0.9×	61 1.6×	15	529
Guofang Hou China	11	592 1.4×	293 1.0×	177 2.1×	50 1.0×	73 1.9×	16	672

Countries citing papers authored by Juhong Wang

Since Specialization

Citations

This map shows the geographic impact of Juhong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juhong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juhong Wang more than expected).

Fields of papers citing papers by Juhong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juhong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juhong Wang. The network helps show where Juhong Wang may publish in the future.

Co-authorship network of co-authors of Juhong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Juhong Wang. A scholar is included among the top collaborators of Juhong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juhong Wang. Juhong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Juhong, Yannan Yang, Fei Shao, et al.. (2024). Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc. Nature Metabolism. 6(5). 914–932. 57 indexed citations breakdown →

He, Haiyan, Liwei Xiao, Juhong Wang, Dong Guo, & Zhimin Lu. (2023). Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2. Cancer Communications. 43(3). 387–390. 22 indexed citations

Wang, Juhong, Fei Shao, Yannan Yang, et al.. (2022). A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability. Cancer Communications. 42(10). 1008–1027. 45 indexed citations

Wang, Juhong, Renda Li, Hong Cheng, et al.. (2022). The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer. Frontiers in Oncology. 12. 899987–899987. 17 indexed citations

Zhu, Rongxuan, Yannan Yang, Fei Shao, et al.. (2022). Choline Kinase Alpha2 Promotes Lipid Droplet Lipolysis in Non-Small-Cell Lung Carcinoma. Frontiers in Oncology. 12. 848483–848483. 11 indexed citations

Sun, Sijin, Kailun Fei, Guochao Zhang, et al.. (2021). Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas. Frontiers in Genetics. 11. 617174–617174. 17 indexed citations

Zhang, Xu, Xiao-Min Yu, Min Zhang, et al.. (2021). Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial. Annals of Palliative Medicine. 10(3). 3277–3285. 5 indexed citations

Sun, Sijin, Yannan Yang, Juhong Wang, et al.. (2021). Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication. Frontiers in Cell and Developmental Biology. 9. 743724–743724. 4 indexed citations

Sun, Sijin, Wei Guo, Fang Lv, et al.. (2021). Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers. Frontiers in Molecular Biosciences. 8. 587436–587436. 12 indexed citations

10.

Yang, Xueying, Fei Shao, Dong Guo, et al.. (2021). WNT/β-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis. Cell Death and Disease. 12(5). 462–462. 102 indexed citations

11.

Shao, Fei, Xueli Bian, Juhong Wang, et al.. (2021). Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma. Frontiers in Oncology. 11. 561247–561247. 13 indexed citations

12.

Wang, Wei, Fei Shao, Xueying Yang, et al.. (2021). METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding. Nature Communications. 12(1). 3803–3803. 121 indexed citations

13.

Ma, Xiao, et al.. (2021). Sesamol Epigenetically Induces Estrogen Receptor α Re-expression by Upregulating miR-370-3p in Estrogen Receptor α-Negative Breast Cancer. Journal of Agricultural and Food Chemistry. 69(31). 8737–8746. 8 indexed citations

14.

Wang, Wei, Xueying Yang, Juhong Wang, et al.. (2021). Author Correction: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding. Nature Communications. 12(1). 4529–4529. 6 indexed citations

15.

Yang, Xueying, Fei Shao, Susheng Shi, et al.. (2019). Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma. Frontiers in Oncology. 9. 1123–1123. 27 indexed citations

16.

Shao, Fei, Xueying Yang, Wei Wang, et al.. (2019). PGK1 Promoter Hypomethylation and PGK1-Mediated PDHK1 Phosphorylation Associate with Stage and Prognosis in Multiple Human Cancers. SSRN Electronic Journal. 1 indexed citations

17.

Shao, Fei, Xueying Yang, Wei Wang, et al.. (2019). Associations of PGK1 promoter hypomethylation and PGK1‐mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan‐cancer analysis. Cancer Communications. 39(1). 54–54. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact